Home
Storia in 1 fonti
Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule
Potentially Valuable Novel Compositions Being Investigated
Raccontata da
morningstar.com
Timeline cronologica
- ·
Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule
Potentially Valuable Novel Compositions Being Investigated
- ·
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
KELOWNA, BC / ACCESS Newswire / June 25, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that…